90 likes | 332 Views
Outline. Intraductal proliferative lesions Usual ductal hyperplasia (UDH) Atypical ductal hyperplasia (ADH) Low grade DCIS Flat epithelial atypia (FEA) Clinical significance and management recommendations Not discussing: lobular neoplasia, intermediate and high grade lesions.
E N D
Outline Intraductal proliferative lesions • Usual ductal hyperplasia (UDH) • Atypical ductal hyperplasia (ADH) • Low grade DCIS • Flat epithelial atypia (FEA) • Clinical significance and management recommendations • Not discussing: lobular neoplasia, intermediate and high grade lesions.
Intraductal proliferative lesions • A group of cytologically and architecturally diverse proliferations originating in the TDLU. • Increased risk for subsequent breast ca – but of vastly different magnitudes. • ‘risk indicators’ VS ‘precursors’ • Different genetics • Different morphology: architecture, cytology, extent.
UDH ADH DCIS INV CA CCL/FEA DIN terminology? UDH ADH HG DCIS LG DCIS INV CA
Genetics of intraductal proliferative lesions H CA Loss 16q FEA/CCL UDH ADH HG DCIS LG DCIS INV CA
Usual ductal hyperplasia • Also known as epithelial hyperplasia of usual type • Mild, moderate, florid – of no clinical significance* • Architecture: solid, fenestrated, micropapillary (tapered), peripheral slit-like lumens, attenuated bridges • Cytology: variable size and shape, overlapping, ill-defined cell borders, streaming of cells, necrosis is allowed. Occasional mitoses allowed. Compare to normal ducts for reference.